INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 1 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $230,380 | +3.9% | 451,725 | -20.8% | 0.17% | -2.4% |
| Q3 2023 | $221,749 | +172.4% | 570,049 | +212.7% | 0.17% | +220.8% |
| Q2 2023 | $81,396 | -32.2% | 182,297 | +24.6% | 0.05% | -36.9% |
| Q1 2023 | $119,966 | -47.6% | 146,300 | -0.5% | 0.08% | -55.8% |
| Q4 2022 | $229,000 | -9.8% | 147,075 | -0.2% | 0.19% | -11.6% |
| Q3 2022 | $254,000 | +12.4% | 147,380 | +12.8% | 0.22% | +313.5% |
| Q2 2022 | $226,000 | -20.4% | 130,601 | +64.9% | 0.05% | -72.9% |
| Q1 2022 | $284,000 | -21.8% | 79,182 | +9.0% | 0.19% | -21.6% |
| Q4 2021 | $363,000 | -22.3% | 72,647 | +11.5% | 0.24% | -23.9% |
| Q3 2021 | $467,000 | -19.5% | 65,168 | +4.2% | 0.32% | -18.5% |
| Q2 2021 | $580,000 | – | 62,566 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |